Published in Blood Weekly, March 23rd, 2000
Researcher Noriko Suzuki and colleagues reported their findings at the conference, "Gene Therapy of Cancer VII," held in San Diego, California.
Peripheral blood lymphocytes are important target cells for gene therapy of various disorders, including neoplastic diseases. However, lymphocytes are quite resistant to transduction with currently used viral vectors such as amphotropic retroviral vectors and adenoviral vectors.
In recent studies, Suzuki et al. showed that HIV vectors pseudotyped with HIV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.